Stocksigma LogoStocksigma Logo

Nephro Care India Discloses H1 Related Party Transactions

Nephro Care India Ltd disclosed related party transactions for the half-year ended 30th Sep'26 under Regulation 23(9) of SEBI LODR

Nephro Care India Discloses H1 Related Party Transactions

Nephro Care India Ltd · Others (Uncategorized) · 12 Nov 2026, 11:24 pm

Nephro Care India Discloses H1 Related Party Transactions Nephro Care India Ltd disclosed related party transactions for the half-year ended 30th Sep'26 under Regulation 23(9) of SEBI LODR. Key transactions included consultancy charges of ₹4.32 cr to Managing Director Pratim Sengupta (outstanding payable ₹86.40 lakh), operational revenue of ₹13.42 lakh from Sampurna Women Care and IFV (receivable ₹25.29 lakh), and blood consumables purchases worth ₹21.67 lakh from Arica Diagnostic Private Limited (payable ₹10.40 lakh). Remuneration to the CFO and Company Secretary stood at ₹16.00 lakh and ₹6.00 lakh, respectively.

Original exchange filing (PDF)

More announcements from Nephro Care India Ltd

All Nephro Care India Ltd announcements